scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00534-002-0842-3 |
P698 | PubMed publication ID | 14714164 |
P2093 | author name string | Masaaki Nakahara | |
Toshinori Ito | |||
Yasuhiro Tanaka | |||
Yoshikazu Morimoto | |||
Toshiro Nishida | |||
Toru Kitagawa | |||
Masahiro Fujikawa | |||
Toshikazu Ito | |||
Hiroyuki Nakaba | |||
Shigetaka Yamamoto | |||
P433 | issue | 6 | |
P921 | main subject | intrahepatic cholangiocarcinoma | Q18556554 |
P304 | page(s) | 432-440 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Journal of Hepato-Biliary-Pancreatic Surgery | Q15750952 |
P1476 | title | Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma | |
P478 | volume | 10 |
Q43987886 | Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study |
Q26865200 | Cancer review: Cholangiocarcinoma |
Q38920606 | Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern |
Q28076098 | Cholangiocarcinoma: Current Knowledge and New Developments |
Q35072802 | Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity |
Q34633986 | Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma |
Q43207600 | Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma |
Q34614931 | Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma |
Q36614705 | Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma |
Q81841566 | Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma |
Q57151083 | Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma |
Q92151158 | EUS-FNA is effective for lymph node staging in patients with cholangiocarcinoma |
Q37316584 | Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. |
Q57149758 | Factors affecting survival after resection of intrahepatic cholangiocarcinoma |
Q43963512 | Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy |
Q38957904 | Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma |
Q40235400 | Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma |
Q33622816 | In-hospital mortality after resection of biliary tract cancer in the United States |
Q82103340 | Intrahepatic cholangiocarcinoma: clinicopathological differences between peripheral type and hilar type |
Q47604930 | Intrahepatic cholangiocarcinoma: prognostic factors after liver resection. |
Q44531650 | Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection |
Q30359582 | Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. |
Q38543212 | Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis. |
Q38258604 | Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review |
Q44700131 | Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma |
Q89503422 | Percutaneous radiofrequency-assisted liver partition versus portal vein embolization before hepatectomy for perihilar cholangiocarcinoma |
Q46587850 | Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass |
Q41732864 | Positron emission tomography (PET) for cholangiocarcinoma |
Q57154434 | Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors |
Q44563329 | Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery |
Q33704511 | Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma |
Q33597837 | Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells |
Q37408964 | Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series |
Q37900232 | Surgical outcomes of intrahepatic cholangiocarcinoma |
Q42244914 | Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study |
Q35047746 | Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years |
Q38743418 | The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis |